Verrica Pharmaceuticals Inc.
Clinical trials sponsored by Verrica Pharmaceuticals Inc., explained in plain language.
-
New hope for stubborn warts: extended treatment shows promise
Disease control Recruiting nowThis study follows people who already took part in earlier trials for common warts. They can receive up to 4 more treatments with YCANTH, a liquid applied to each wart every 21 days. The goal is to see if the treatment is safe and can clear all warts over about a year. Around 600…
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 05:47 UTC
-
New gel could zap away common warts
Disease control Recruiting nowThis study tests a gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older will apply the gel to their warts to see if it clears them completely by day 84. The goal is to find a safe and effective treatment for warts on the body.
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 05:31 UTC